Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency
通过一种导致 17,20 裂解酶缺乏的新型 V366M 突变揭示人类 CYP17A1 的双重活性及其与抗前列腺癌药物阿比特龙的结合机制
期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph11020037
Fernández-Cancio, Mónica; Camats, Núria; Flück, Christa E; Zalewski, Adam; Dick, Bernhard; Frey, Brigitte M; Monné, Raquel; Torán, Núria; Audí, Laura; Pandey, Amit V
